Johnson & Johnson exceeded the anticipated earnings per share (EPS) of $2.28, showcasing operational efficiency and resilience in a complex global business environment.
source: https://tokenist.com/johnson-johnson-jnj-surpasses-2-28-eps-expectation-in-q4/?utm_source=rss&utm_medium=rss&utm_campaign=johnson-johnson-jnj-surpasses-2-28-eps-expectation-in-q4